Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-19

FDA Approved: LEDIPASVIR AND SOFOSBUVIR — Supplemental Application (Asegua Therapeutics LLC)

View source ↗

Summary

The FDA approved a supplemental application for Ledipasvir and Sofosbuvir submitted by Asegua Therapeutics LLC, resulting in an approved modification to the pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ledipasvir and Sofosbuvir (Ledipasvir and Sofosbuvir)

Snippet

SUPPL AP for LEDIPASVIR AND SOFOSBUVIR (LEDIPASVIR AND SOFOSBUVIR)